These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 18450730)
21. Metachromatic leukodystrophy and transplantation: remyelination, no cross-correction. Wolf NI; Breur M; Plug B; Beerepoot S; Westerveld ASR; van Rappard DF; de Vries SI; Kole MHP; Vanderver A; van der Knaap MS; Lindemans CA; van Hasselt PM; Boelens JJ; Matzner U; Gieselmann V; Bugiani M Ann Clin Transl Neurol; 2020 Feb; 7(2):169-180. PubMed ID: 31967741 [TBL] [Abstract][Full Text] [Related]
22. Hodgkin's lymphoma relapsing after autologous transplantation: allogeneic hematopoietic stem cell transplantation using a strategy of reduced intensity conditioning, and T-cell depletion with T-cell add-back. Verholen F; Terrettaz M; Roosnek E; Passweg JR; Chalandon Y Eur J Haematol; 2009 Sep; 83(3):273-5. PubMed ID: 19500136 [No Abstract] [Full Text] [Related]
25. Reduced-intensity conditioning for severe aplasia using fludarabine and CY followed by infusion of ex vivo T-cell-depleted grafts leads to excellent engraftment and absence of GVHD. Novitzky N; Thomas V; du Toit C; McDonald A Bone Marrow Transplant; 2009 May; 43(10):779-85. PubMed ID: 19079315 [TBL] [Abstract][Full Text] [Related]
26. Juvenile metachromatic leukodystrophy 10 years post transplant compared with a non-transplanted cohort. Krägeloh-Mann I; Groeschel S; Kehrer C; Opherk K; Nägele T; Handgretinger R; Müller I Bone Marrow Transplant; 2013 Mar; 48(3):369-75. PubMed ID: 22941383 [TBL] [Abstract][Full Text] [Related]
27. The A-B-C of haematopoietic stem cell transplantation. Rafeah NT; Fadilah SA Med J Malaysia; 2009 Mar; 64(1):94-100; quiz 101. PubMed ID: 19852335 [TBL] [Abstract][Full Text] [Related]
28. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO). Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A; Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030 [TBL] [Abstract][Full Text] [Related]
30. Mesenchymal stem cells for the treatment of refractory pure red cell aplasia after major ABO-incompatible hematopoietic stem cell transplantation. Fang B; Song Y; Li N; Li J; Han Q; Zhao RC Ann Hematol; 2009 Mar; 88(3):261-6. PubMed ID: 18769919 [TBL] [Abstract][Full Text] [Related]
31. A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis. Gupta V; Kröger N; Aschan J; Xu W; Leber B; Dalley C; Sabloff M; Lipton JH; Messner H; Brune M Bone Marrow Transplant; 2009 Sep; 44(5):317-20. PubMed ID: 19234505 [No Abstract] [Full Text] [Related]
38. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848 [TBL] [Abstract][Full Text] [Related]
39. Hematopoietic cell transplantation from an HLA-mismatched familial donor is feasible without ex vivo-T cell depletion after reduced-intensity conditioning with busulfan, fludarabine, and antithymocyte globulin. Lee KH; Lee JH; Lee JH; Kim DY; Kim SH; Shin HJ; Lee YS; Kang YA; Seol M; Ryu SG Biol Blood Marrow Transplant; 2009 Jan; 15(1):61-72. PubMed ID: 19135944 [TBL] [Abstract][Full Text] [Related]